Anti-Kappa (κ) CE/IVD antibodies for immunohistochemistry (IHC) are widely used tools in hematopathology for assessing B-cell clonality and plasma cell differentiation. Demonstration of immunoglobulin light chain restriction is a well-established diagnostic principle in the evaluation of lymphoid and plasma cell neoplasms.
Biological Significance of Kappa (κ) Light Chains
Immunoglobulins are composed of two heavy chains and two light chains, with light chains being either κ or λ and expressed in a mutually exclusive manner by individual B cells. κ light chains are encoded by the IGK locus and form part of both membrane-bound B-cell receptors and secreted antibodies, contributing to antigen recognition. During normal B-cell development, a physiological κ:λ ratio of approximately 1.5:1 to 3:1 is observed in human tissues. This balanced distribution underpins the use of light chain expression as a marker of clonality.
Diagnostic Utility in Hematopathology
- Clonality assessment: Predominant or monotypic κ expression (κ≫λ) supports a monoclonal B-cell population, a key feature of B-cell lymphomas and plasma cell neoplasms.
- Reactive vs neoplastic distinction: Polyclonal infiltrates demonstrate a mixture of κ and λ expression, whereas light chain restriction favors a neoplastic process, although results should be interpreted in context.
- Broad diagnostic application: Relevant in the evaluation of entities such as multiple myeloma, lymphoplasmacytic lymphoma, and other mature B-cell neoplasms.
- Tissue-based analysis: IHC enables visualization of κ expression within the architectural context of formalin-fixed paraffin-embedded (FFPE) tissues.
Key Features of Anti-Kappa CE/IVD Antibodies (IHC)
- High specificity: Selective detection of κ light chains with minimal cross-reactivity to λ chains in validated assays.
- FFPE compatibility: Optimized for routine workflows using heat-induced or enzymatic antigen retrieval.
- Clonality marker: Detects cytoplasmic and/or surface immunoglobulin in B cells and plasma cells.
- Reproducibility: Reliable performance under standardized laboratory protocols.
- Versatility: Applicable across a broad range of lymphoid tissues and hematologic malignancies.
